XML 42 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Expense The Company recognizes stock-based compensation in the consolidated statements of income, based on the department to which the related employee reports, as follows:
Three Months Ended March 31,
20222021
(in thousands)
Cost of net revenue$163 $169 
Research and development9,676 7,162 
Selling, general and administrative8,715 5,624 
$18,554 $12,955 
Summary of Restricted Stock Unit Activity A summary of the Company’s restricted stock unit activity is as follows:
Number of Shares
(in thousands)
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 20215,233 $25.14 
  Granted1,502 63.44 
  Vested(730)56.13 
  Canceled(108)25.66 
Outstanding at March 31, 20225,897 $31.05 
Summary of Performance-Based Restricted Stock Unit Activity
A summary of the Company’s performance-based restricted stock unit activity is as follows:
Number of Shares
(in thousands)
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 20212,005 $19.80 
  Granted(1)
376 75.40 
  Vested(701)17.85 
  Canceled(1)35.57 
Outstanding at March 31, 20221,679 $33.05 
________________
(1) Number of shares granted is based on the maximum percentage achievable in the performance-based restricted stock unit award.
Employee Stock Purchase Plan, Valuation Assumptions The fair values of employee stock purchase rights were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:
Three Months Ended March 31,
20222021
Weighted-average grant date fair value per share$18.82 $8.66 
Risk-free interest rate0.06 %0.12 %
Dividend yield— %— %
Expected life (in years)0.500.50
Volatility43.83 %59.72 %
Summary of Stock Option Activity A summary of the Company’s stock options activity is as follows:
Number of Options
(in thousands)
Weighted-Average Exercise PriceWeighted-Average Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2021417 $17.05 
Exercised(6)13.42 
Outstanding at March 31, 2022411 $17.10 3.07$16,947 
Vested and expected to vest at March 31, 2022411 $17.10 3.07$16,947 
Exercisable at March 31, 2022383 $17.00 3.04$15,831